Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Premium pricing policy

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed may work with the Commerce Department to address premium pricing concerns via the second report on the Regulatory Reform Initiative by the U.S. Trade Representative and Japan, expected by October. The first annual report was released June 26 (1"The Gray Sheet" July 1, 2002, In Brief). The effects of the policy, which allows devices to receive a temporary price within 90 days of launch and guarantees a permanent price within six months, should become clearer following several months of implementation and a "working level" AdvaMed trip to Japan in July. The trade group also will help guide the agenda of a health economics conference in Tokyo, currently scheduled for Sept. 19...

You may also be interested in...

U.S.-Japan regulatory reform

AdvaMed is working with the Commerce Department to prepare the federal government's September/October submission of issues to be addressed by the Regulatory Reform Initiative. Released June 26, the1 U.S. Trade Representative/Japan's first annual report on the initiative represents "solid first steps in solving the current health care crisis in Japan," according to the association. Absent from the report, which lists such planned reforms as increasing the frequency of reimbursement price redesignations, are U.S. industry's concerns with Japanese foreign reference pricing. A Commerce official noted that the topic of reference pricing was excluded from the final report because the U.S. did not want to lend credence to a policy it opposes...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts